SREBF1 and breast carcinoma: NONO binds to nuclear SREBP1a via residue Y267 and increases nuclear SREBP1a protein stability, thereby stimulating breast cancer cell proliferation and tumor growth in vitro and in vivo (Zhu et al., 2016).